64 research outputs found

    In Urban Areas of Sivas City the Determination of Bone Mineral Density Reference Values of Healthy Women Who Admitted to Cumhuriyet University Hospital Physical Medicine and Rehabilitation Outpatient Clinic

    No full text
    Objective: Osteoporosis and its results of fractures became a major health problem worldwide. Classification of OP by WHO based on Bone Mineral Density (BMD) measurements, and therefore it’s definite measurement is the major tool for OP diagnosis. There are many ways to measure BMD. The mostly used technique is Dual-Energy-X-Ray Absorptiometry (DXA). Our aim in this study was to determine BMD reference values among healthy women in Sivas by using DXA. Materials and Methods: 350 volunteered women between ages 20-79 who came to Cumhuriyet University Department of Physical Medicine and Rehabilitation took place in this study. A survey form was used to exclude women who have problems that may lead to secondary osteoporosis, who are pregnant, breast feeding, being already treated for osteoporosis, and located outside Sivas county area. Women who met the criteria, are tested for their lumbar vertebrae (L1-L4) and left hip (femur neck, trochanter, total hip) BMD values by DXA method (Hologic QDR 4500 W). Results: Obtained BMD values classified in 6 groups based on decades (from 20-29 to 70-79). Obtained BMD values evaluated statistically and BMD reference values for age groups in Sivas county area are determined. Conclusion: In our study mean BMD values between ages 20-49 are stable for spinal and femoral levels. In our study mean BMD values for lumbar area varies between 1.01 gr/cm2 - 0.96 gr/cm2, for femoral area varies between 0.91 gr/cm2-0.89 gr/cm2 among women who are between 20-49 years old and reaches peak values in both femoral and spinal area between 30-39 age group. As a result we determined BMD reference values of healthy women in Sivas county area in our study. (Turkish Journal of Osteoporosis 2014;20: 104-9

    Postmenopozal Osteoporozda Klinik Risk Faktörlerinin Sıklığı

    No full text
    Amaç: Bu çalışmada postmenopozal kadınlarda osteoporoz ile ilişkilendirilen klinik risk faktörlerinin sıklığı belirlendi.Hastalar ve yöntemler: Bu kesitsel, gözlemsel, çokmerkezli çalışmada toplam 730 postmenopozal kadın osteoporozun klinik risk faktörleri açısından değerlendirildi. Değerlendirmede şu klinik risk faktörlerinin kaydedildiği standart bir sorgulama formu kullanıldı: ailesel ve kişisel kırık öyküsü, uzamış hareketsizlik, güneş maruziyeti, yaşam boyu hareketsiz yaşam biçimi, sigara kullanımı, çocukluk ve erişkinlik döneminde düşük kalsiyum alımı, aşırı kafein alımı, yüksek sodyum alımı, yetersiz protein alımı, gebelik sayısı, menopoz yaşı, prematür menopoz varlığı, primer ve sekonder amenore, tıbbi hastalıklar ve kronik reçeteli ilaç kullanımı.Bulgular: Osteoporoz açısından en sık rastlanan klinik risk faktörleri, yetersiz güneş maruziyeti (%53.3), mevcut hareketsiz yaşam biçimi (%52.9), erişkin (%45.1) ve çocukluk çağında (%41.9) düşük kalsiyum alımı ve ergenlik döneminde hareketsiz yaşam biçimi (%27.9) idi. Toplam 707 hasta (%96.5) birden fazla klinik risk faktörü tanımlarken, hastaların %74.3'ü sekonder osteoporoz açısından en az bir klinik risk faktörü bildirdi.Sonuç: Yeterli güneş maruziyeti, çocukluktan itibaren beslenmede yeterli kalsiyum alımı ve hareketli bir yaşam biçimi, postmenopozal kadınların osteoporozdan korunmasında rol oynayabilir. Buna ilave olarak, hekimler bu hasta grubundaki yüksek sekonder osteoporoz olasılığının farkında olmalıdırlar.Objectives: This study aims to identify the frequency of clinical risk factors associated with osteoporosis in postmenopausal women. Patients and methods: In this cross-sectional, observational, multicenter study, a total of 730 postmenopausal women were assessed for risk factors associated with osteoporosis. The assessment included a standardized questionnaire which recorded the following clinical risk factors: family and personal histories of fractures, prolonged immobilization, sun exposure, lifelong sedentary lifestyle, smoking history, low calcium intake in childhood and adulthood, excessive caffeine intake, high sodium intake, inadequate protein intake, number of pregnancies, age at menopause, the presence of premature menopause, primary and secondary amenorrhea, medical conditions, and chronic use of prescription drugs. Results: The most frequent clinical risk factors for osteoporosis were inadequate sun exposure (53.3%), current sedentary lifestyle (52.9%), low calcium intake in adulthood (45.1%) and childhood (41.9%), and sedentary lifestyle in adolescence (27.9%). A total of 707 patients (96.5%) described more than one risk factor, while 74.3% of the patients reported one clinical risk factor at least for secondary osteoporosis. Conclusion: Adequate sun exposure and proper intake of dietary calcium beginning in childhood combined with lifelong daily physical activity may play a role in preventing osteoporosis in postmenopausal women. In addition, physicians should be aware of the high probability of secondary osteoporosis in this patient group

    The anti-osteoporotic drug preferences of physiatrists: A multicenter descriptive study

    No full text
    Amaç: Bu çok merkezli tanımlayıcı araştırmanın amacı ülkemizdeki fiziatristlerin birincil ve ikincil osteoporozu olan hastalarda anti-osteoporotik ilaç tercihlerini saptamaktır. Gereç ve Yöntemler: Çalışma Türkiye’nin 10 ilinde yürütüldü. Osteoporoz tanısı; dual-energy x-ray absorptiometry kullanılarak Dünya Sağlık Örgütü kriterlerine göre konuldu. Omurga ve–veya kalçada T skoru ?-2,5 olan hastalar osteoporotik olarak kabul edildi. Çalışmaya 18 yaş üstünde birincil veya ikincil osteoporozu olan 714 hasta alındı. Hastaların sosyodemografik özelliklerinin yanı sıra olarak ikincil osteoporoza neden olan kronik ilaç kullanımı ve-veya ek sistemik hastalıkları sorgulandı ve hekimleri tarafından önerilen anti-osteoporotik ilaçları kaydedildi. Bulgular: Hem birincil hem de ikinci osteoporozu olan hastalarda hekimlerin öncelikli tedavi seçeneği olarak vitamin D ve kalsiyum kullandıkları, medikal tedavi seçenekleri içinde ise ilk tercihlerinin bifosfonat grubundan alendronat olduğu saptandı. Bunları birincil osteoporoz grubunda ibandronat, risedronat, stronsiyum ranelat, kalsitonin, zoledronat, raloksifen, paratiroid hormon (PTH) ve hormon replasman tedavisinin (HRT) izlediği, ikincil osteoporoz grubunda ise risedronat, ibandronat, kalsitonin, stronsiyum ranelat, zoledronat, PTH, HRT ve raloksifenin izlediği belirlendi. Sonuç: Hekimler hastanın kırık riskini, tıbbi öyküsünü, osteoporoz için uygulanan önceki tedavilerini, diğer hastalıklarını, tedavi kaynaklı riskleri ve yararları, finansal maliyet ve potansiyel yarar ilişkisini de göz önüne alarak hasta için en uygun tedaviyi seçmelidir. (Türk Os­te­opo­roz Dergisi 2012;18: 42-6)Aim: The purpose of this multicenter descriptive study is to determine the preferences of physiatrists in our country for anti-osteoporotic drugs in patients with primary and secondary osteoporosis. Materials and Methods: This study was carried out in 10 provinces of Turkey. The diagnosis of osteoporosis was based on World Health Organization criteria using dual-energy x-ray absorptiometry. Patients with a spine and/or hip T-score ≤-2.5 were considered as osteoporotic. 714 patients over 18 years old with primary or secondary osteoporosis were included in the study. In addition to socio-demographic characteristics and chronic use of medications and/or additional systemic diseases that cause secondary osteoporosis were questioned and antiosteoporotic drugs that are recommended by their physicians were recorded.Results: The physicians’ preferred vitamin D and calcium as the prior treatment both in primary and secondary osteoporosis. The most commonly used anti-osteoporotic agent was alendronate from the biphosphonate group. It was followed by ibandronate, risedronate, strontium ranelate, calcitonin, zoledronate, raloxifene, parathyroid hormone (PTH) and hormone replacement therapy (HRT) in the primary osteoporosis and risedronate, ibandronate, calcitonin, strontium ranelate, zoledronate, PTH, HRT and raloxifene in the secondary osteoporosis, respectively. Conclusion: The physician should choose the most suitable treatment for the patient based on fracture risk, medical history, previous treatments for osteoporosis, concomitant diseases, treatment-induced risks and benefits, and the relation between financial cost and potential benefit. (Turkish Journal of Osteoporosis 2012;18: 42-6

    Polypharmacy in the Elderly: A Multicenter Study

    No full text
    WOS: 000270438400009PubMed: 19716065Objective: The aim of this study was to evaluate the polypharmacy issue and its correlations with socio-economic variables in Turkish elderly patients. Design: Cross-sectional Setting: Outpatient clinics of the medical schools, departments of physical medicine and rehabilitation from 12 provinces. Participants: A total of 1430 elderly in different geographical regions of Turkey during January 2007 to January 2008 were included. Measurements: Patients were interviewed using a questionnaire that included demographic characteristics, current medical diagnosis, and pharmaceuticals that are used by elderly. Demographical parameters were gender, age, marital status, number of children, level of education, province, and status of retirement. Results: The mean number of drugs was found to be higher in the females. There was a significant difference among age groups, marital status groups, and the number of children categories. The distribution of the number of drugs among education levels did not differ significantly, whereas the distribution of the number of drugs between the status of retirement and presence of chronic disease differed significantly. Conclusions: Polypharmacy is correlated with various factors including age, sex, marital status, number of children, status of retirement, and presence of chronic medical conditions but not educational status in our study group. (J Am Med Dir Assoc 2009; 10: 486-490

    Validity, reliability, and factor structure of the Istanbul Low Back Pain Disability Index in axial spondyloarthritis

    No full text
    Objective: To investigate the validation and reliability of Istanbul Low Back Pain Disability Index (ILBPDI) in axial spondyloarthritis (Ax-SpA). Methods: Patients with Ax-SpA according to The Assessment of SpondyloArthritis International Society criteria were recruited. The validation was assessed by face, content, and construct (convergent and divergent) validities, whereas the reliability was assessed by internal consistency and test-retest reliability. Factor analysis was performed. Convergent validity was assessed by correlations of ILBPDI with functional parameters (The Bath Ankylosing Spondylitis Functional Index, The Dougados Functional Index, and The Health Assessment Questionnaire). Divergent validity was assessed by correlations of ILBPDI with non-functional parameters. Results: Two hundred forty patients were recruited. Cognitive debriefing showed ILBPDI to be clear, relevant, and comprehensive. Cronbach's alpha coefficient was 0.953. The test-retest reliability was good with the intraclass correlation coefficient of 0.870. ILBPDI was represented by three-factor groups of activity: axial bending, sitting/rest, and standing activities. ILBPDI had good correlations with the functional parameters (rho changes between 0.809 and 0.580), and it had poor or non-significant correlations with the non-functional parameters (absolute rho changes between 0.669 and 0.001). Conclusion: ILBPDI is a practical, accurate, and non-time-consuming scale which is valid and reliable to evaluate the functional disability in patients with Ax-SpA

    Polypharmacy in the Elderly: A Multicenter Study

    No full text
    Objective: The aim of this study was to evaluate the polypharmacy issue and its correlations with socio-economic variables in Turkish elderly patients

    Polypharmacy in the Elderly: A Multicenter Study

    No full text
    WOS: 000270438400009PubMed ID: 19716065Objective: The aim of this study was to evaluate the polypharmacy issue and its correlations with socio-economic variables in Turkish elderly patients. Design: Cross-sectional Setting: Outpatient clinics of the medical schools, departments of physical medicine and rehabilitation from 12 provinces. Participants: A total of 1430 elderly in different geographical regions of Turkey during January 2007 to January 2008 were included. Measurements: Patients were interviewed using a questionnaire that included demographic characteristics, current medical diagnosis, and pharmaceuticals that are used by elderly. Demographical parameters were gender, age, marital status, number of children, level of education, province, and status of retirement. Results: The mean number of drugs was found to be higher in the females. There was a significant difference among age groups, marital status groups, and the number of children categories. The distribution of the number of drugs among education levels did not differ significantly, whereas the distribution of the number of drugs between the status of retirement and presence of chronic disease differed significantly. Conclusions: Polypharmacy is correlated with various factors including age, sex, marital status, number of children, status of retirement, and presence of chronic medical conditions but not educational status in our study group. (J Am Med Dir Assoc 2009; 10: 486-490

    Differentiation of Rheumatoid Arthritis From HCV Infection: Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide or Anti-Mutated Citrullinated Vimentin?

    No full text
    Objective: Differentiation of rheumatoid arthritis (RA) from other diseases with joint involvement such as hepatitis-C virus (HCV) infection represents a diagnostic problem. In addition to the rheumatoid factor (RF), more specific and sensitive autoantibodies are under evaluation in recent years with conflicting results. In this study, we tested the diagnostic value of rheumatoid factor, anti-cyclic citrullinated peptide (anti-CCP) and antimutated citrullinated vimentin (anti-MCV) in distinguishing RA from hepatitis C patients. Materials and Methods: Sera of 34 RA patients and 30 hepatitis C patients were tested for RF, anti-CCP anti-MCV. Disease activity was determined by disease activity score (DAS-28) 28 in RA and by modified Knodell score in hepatitis C patients. Extra-articular involvement in RA and rheumatologic involvement in hepatitis
    corecore